NCT02379416 2026-04-01Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid TumorsNational Institutes of Health Clinical Center (CC)Phase 1 Completed47 enrolled
NCT00441155 2013-05-13Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With ImatinibNovartisPhase 1 Completed14 enrolled